Global Cord Blood Corp (CORBF)
OTCMKTS: CORBF · Delayed Price · USD
1.250
-0.100 (-7.41%)
Apr 25, 2024, 3:58 PM EDT - Market closed

Company Description

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China.

The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province.

The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018.

Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Global Cord Blood Corp
Global Cord Blood logo
Country Hong Kong
Founded 2009
Industry Diagnostics & Research
Sector Healthcare
Employees 1,202

Contact Details

Address:
48 Fl., Bank Of China Tower, 1 Garden Road
Central Hong Kong, K3 000000
Hong Kong
Phone 852-3605-8180

Stock Details

Ticker Symbol CORBF
Exchange OTCMKTS
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001467808
CUSIP Number G39342103
ISIN Number US6986591096
SIC Code 8090

Key Executives

Name Position
Ting Zheng Chief Executive Officer and CEO of Beijing Division
Bing Chuen Chen Chief Financial Officer
Xin Xu Chief Technology Officer
Rui Arashiyama Chief Executive Officer of Guangdong and Zhejiang Divisions
Cathy Bai Vice President of Corporate Finance

Latest SEC Filings

Date Type Title
Apr 25, 2024 6-K Report of foreign issuer
Apr 17, 2024 6-K Report of foreign issuer
Mar 19, 2024 6-K Report of foreign issuer
Mar 11, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Mar 11, 2024 6-K Report of foreign issuer
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024 6-K Report of foreign issuer
Dec 4, 2023 6-K Report of foreign issuer
Sep 29, 2023 6-K Report of foreign issuer
Sep 5, 2023 6-K Report of foreign issuer